The 22nd Bio段uity Europe

16-18 May, 2022
Milan, Italy

51蹤獲 will attend the 22nd Bio段uity Europe, the Europes premier international showcase for financial dealmakers and biopharma executives to meet rising biotechs.
51蹤獲s team will reconnect with investors and partners to accelerate the clinical development of its lead compound Vonafexor focused on kidney and liver diseases.
Jacky Vonderscher will also present VONAFEXOR, a fibrolytic and anti-inflammatory for the treatment of kidney and liver diseases in the Hot Topics Track #1 session, 16:30 pm -16:42 pm, May 17

Read next in 'Events'